» Articles » PMID: 33905266

Targeting MicroRNAs by Curcumin: Implication for Cancer Therapy

Overview
Date 2021 Apr 27
PMID 33905266
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

In spite of all the investigations in the past 20 years that established a great body of knowledge in cancer therapy, utilizing some elderly methods such as plant compound administration might still be useful. Curcumin is a bioactive polyphenol, which has many anticancer properties but its capability in modulating miRNA expression has opened new doors in the field of cancer-targeted therapy. MiRNAs are a class of small noncoding RNAs that are able to regulate gene expression and signaling. In addition, some other effects of these RNAs such as modulating cell differentiation and regulation of cell cycle have made miRNAs great candidates for personalized cancer treatment. In this review, we try to find some answers to the questions on how curcumin exerts its impacts on cancer hallmarks through miRNAs and whether chemotherapy can be replaced by this beneficial plant compound.

Citing Articles

LINC00899 suppresses the progression of triple-negative breast cancer via the miRNA-425/PTEN axis and is a biomarker for neoadjuvant chemotherapy efficacy.

Niu L, Bai Y, Yu M, Sun X J Cancer. 2025; 16(5):1647-1655.

PMID: 39991583 PMC: 11843232. DOI: 10.7150/jca.100619.


The Association Between Anti-Neoplastic Effects of Curcumin and Urogenital Cancers: A Systematic Review.

Mazaheri-Tehrani S, Rouzbahani S, Heidari-Beni M Biomed Res Int. 2024; 2024:9347381.

PMID: 39445208 PMC: 11496585. DOI: 10.1155/2024/9347381.


The role of polyphenols in overcoming cancer drug resistance: a comprehensive review.

Dana P, Sadoughi F, Asemi Z, Yousefi B Cell Mol Biol Lett. 2022; 27(1):1.

PMID: 34979906 PMC: 8903685. DOI: 10.1186/s11658-021-00301-9.